Search

Author/Creator Ferrero, Elisabetta

1. 3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target. Issue 6 (28th November 2018)

Authors:
Villa, Antonello; Belloni, Daniela; Vergani, Barbara; Cenci, Simone; Cavalli, Giulio; Biavasco, Riccardo; Rodolfo, Monica; Cangi, Maria Giulia; Doglioni, Claudio; Dagna, Lorenzo; Ferrero, Elisabetta; Ferrarini, Marina
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78:Issue 6(2019)
Page Start:
862
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis. (23rd November 2021)

Authors:
Ferrero, Elisabetta; Villa, Antonello; Stefanoni, Davide; Nemkov, Travis; D'Alessandro, Angelo; Tengesdal, Isak; Belloni, Daniela; Molteni, Raffaella; Vergani, Barbara; De Luca, Giacomo; Grassini, Greta; Cangi, Maria Giulia; Dagna, Lorenzo; Doglioni, Claudio; Cavalli, Giulio; Ferrarini, Marina
Journal:
Rheumatology
Issue:
Volume 61:Number 4(2022)
Page Start:
e93
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease. (2nd July 2016)

Authors:
Ferrero, Elisabetta; Corti, Angelo; Haroche, Julien; Belloni, Daniela; Colombo, Barbara; Berti, Alvise; Cavalli, Giulio; Campochiaro, Corrado; Villa, Antonello; Cohen-Aubart, Fleur; Amoura, Zahir; Doglioni, Claudio; Dagna, Lorenzo; Ferrarini, Marina
Journal:
Oncoimmunology
Issue:
Volume 5:Number 7(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗